One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have ...

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

Abbott (NYSE:ABT) today unveiled a new initiative addressing the biases and stigmas associated with diabetes management.

Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using ...

When you buy through our links, we may earn a commission. Learn more› By Dave Gershgorn Dave Gershgorn is a writer covering monitors, laptops, and tablets. He is a certified display calibrator ...

Medical device and healthcare company Abbott has opened a new facility in Kilkenny, which is expected to employ 800 people.

Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.

With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...

Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...